Learn About Amaurosis Fugax

What is the definition of Amaurosis Fugax?

Amaurosis fugax is a temporary loss of vision in one or both eyes due to a lack of blood flow to the retina. The retina is the light-sensitive layer of tissue at the back of the eyeball.

What are the alternative names for Amaurosis Fugax?

Transient monocular blindness; Transient monocular visual loss; TMVL; Transient monocular visual loss; Transient binocular visual loss; TBVL; Temporary visual loss - amaurosis fugax

What are the causes of Amaurosis Fugax?

Amaurosis fugax is not itself a disease. Instead, it is a sign of other disorders. Amaurosis fugax can occur from different causes. One cause is when a blood clot or a piece of plaque blocks an artery in the eye. The blood clot or plaque usually travels from a larger artery, such as the carotid artery in the neck or an artery in the heart, to an artery in the eye.

Plaque is a hard substance that forms when fat, cholesterol, and other substances build up in the walls of arteries. Risk factors include:

  • Heart disease, especially irregular heartbeat
  • Alcohol abuse
  • Cocaine use
  • Diabetes
  • Family history of stroke
  • High blood pressure
  • High cholesterol
  • Increasing age
  • Smoking (people who smoke one pack a day double their risk for a stroke)

Amaurosis fugax can also occur because of other disorders such as:

  • Other eye problems, such as inflammation of the optic nerve (optic neuritis)
  • Blood vessel disease called polyarteritis nodosa
  • Migraine headaches
  • Brain tumor
  • Head injury
  • Multiple sclerosis (MS), inflammation of the nerves due to the body's immune cells attacking the nervous system
  • Systemic lupus erythematosus, an autoimmune disease in which the body's immune cells attack healthy tissue throughout the body
What are the symptoms of Amaurosis Fugax?

Symptoms include the sudden loss of vision in one or both eyes. This usually lasts for a few seconds to several minutes. Afterward, vision returns to normal. Some people describe the loss of vision as a gray or black shade coming down over the eye.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Amaurosis Fugax?

Treatment of amaurosis fugax depends on its cause. When amaurosis fugax is due to a blood clot or plaque, the concern is to prevent a stroke. The following can help prevent a stroke:

  • Avoid fatty foods and follow a healthy, low-fat diet. Do not drink more than 1 to 2 alcoholic drinks a day.
  • Exercise regularly: 30 minutes a day if you are not overweight; 60 to 90 minutes a day if you are overweight.
  • Quit smoking.
  • Most people should aim for a blood pressure below 120 to 130/80 mm Hg. If you have diabetes or have had a stroke, your provider may tell you to aim for a lower blood pressure.
  • If you have diabetes, heart disease, or hardening of the arteries, your LDL (bad) cholesterol should be lower than 70 mg/dL. Some experts recommend an even lower target, below 55 mg/dL.
  • Follow your provider's treatment plans if you have high blood pressure, diabetes, high cholesterol, or heart disease.

Your provider may also recommend:

  • No treatment. You may only need regular visits to check the health of your heart and carotid arteries.
  • Aspirin, warfarin (Coumadin), or other blood-thinning medicines to lower your risk for stroke.

If a large part of the carotid artery appears blocked, carotid endarterectomy surgery is done to remove the blockage. The decision to do surgery is also based on your overall health.

Who are the top Amaurosis Fugax Local Doctors?
Joseph S. Pulido
Distinguished in Amaurosis Fugax
Ophthalmology
Distinguished in Amaurosis Fugax
Ophthalmology

Retinovitreous Associates Ltd

840 Walnut St, 1020 Mid Atlantic Retina, 
Philadelphia, PA 
 (241.7 mi)
Languages Spoken:
English

Joseph Pulido is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Pulido and is rated as a Distinguished provider by MediFind in the treatment of Amaurosis Fugax. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Uveal Melanoma, Vitrectomy, and Trabeculectomy.

Advanced in Amaurosis Fugax
Ophthalmology
Advanced in Amaurosis Fugax
Ophthalmology

University Of Pittsburgh Physicians

200 Lothrop St, 
Pittsburgh, PA 
 (39.6 mi)
Experience:
5+ years
Languages Spoken:
English

Aditya Uppuluri is an Ophthalmologist in Pittsburgh, Pennsylvania. Dr. Uppuluri has been practicing medicine for over 5 years and is rated as an Advanced provider by MediFind in the treatment of Amaurosis Fugax. His top areas of expertise are Endophthalmitis, Retinal Artery Occlusion, Amaurosis Fugax, Retinal Vein Occlusion, and Vitrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Amaurosis Fugax
Family Medicine
Advanced in Amaurosis Fugax
Family Medicine

Mercer Bucks Medical Associates PC

1411 Woodbourne Rd, 
Levittown, PA 
 (256.9 mi)
Languages Spoken:
English

Anton Furman is a Family Medicine provider in Levittown, Pennsylvania. Dr. Furman and is rated as an Advanced provider by MediFind in the treatment of Amaurosis Fugax. His top areas of expertise are Dementia, Hypertensive Heart Disease, Dysgraphia, Gastrostomy, and Ureteroscopy.

What is the outlook (prognosis) for Amaurosis Fugax?

Amaurosis fugax increases your risk for stroke.

When should I contact a medical professional for Amaurosis Fugax?

Contact your provider if any vision loss occurs. If symptoms last longer than a few minutes or if there are other symptoms with the vision loss, seek medical attention right away.

What are the latest Amaurosis Fugax Clinical Trials?
Impact of Significant Carotid Stenosis on Retinal Perfusion Measured Via Automated Retinal Oximetry

Background: Large vessel carotid stenosis represent significant cause of ischaemic stroke. Indication for surgical revascularisation treatment relies on severity stenosis and clinical symptoms. Mild clinical symptoms such as transient ischemic attack, amaurosis fugax or minor stroke preceded large strokes in only 15% of cases. Aim: The aim of this prospective study is to evaluate whether retinal perfusion is ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
What are the Latest Advances for Amaurosis Fugax?
Who are the sources who wrote this article ?

Published Date: June 13, 2024
Published By: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School at Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Biller J, Schneck MJ, Ruland S. Ischemic cerebrovascular disease. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 65.

Brown GC, Sharma S, Brown MM. Ocular ischemic syndrome. In: Sadda SVR, Sarraf D, Freund KB, et al, eds. Ryan's Retina. 7th ed. Philadelphia, PA: Elsevier; 2023:chap 61.

Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-Cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;80(14):1366-1418. PMID: 36031461 pubmed.ncbi.nlm.nih.gov/36031461/.